ALUR.WS icon

Allurion Technologies Warrants

0.0336 USD
+0.0023
7.35%
Updated May 20, 9:36 AM EDT
1 day
7.35%
5 days
-16.00%
1 month
16.26%
3 months
-24.83%
6 months
-16.00%
Year to date
-3.72%
1 year
-84.00%
5 years
-96.77%
10 years
-96.77%
 

About: Allurion Technologies Inc is a medical device company that focuses on creating a weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.

Employees: 137

0
Funds holding %
of 7,202 funds
Analysts bullish %

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

0.54% less ownership

Funds ownership: 6.35% [Q4 2024] → 5.81% (-0.54%) [Q1 2025]

13% less funds holding

Funds holding: 38 [Q4 2024] → 33 (-5) [Q1 2025]

50% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 4

57% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 7

58% less capital invested

Capital invested by funds: $601K [Q4 2024] → $253K (-$349K) [Q1 2025]

Research analyst outlook

We haven’t received any recent analyst ratings for ALUR.WS.

Financial journalist opinion

We haven’t received any recent news articles for ALUR.WS.

Charts implemented using Lightweight Charts™